Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Détails
Télécharger: jitc-2023-006877.pdf (187.68 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_0C82ABD0A663
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Périodique
Journal for immunotherapy of cancer
ISSN
2051-1426 (Electronic)
ISSN-L
2051-1426
Statut éditorial
Publié
Date de publication
02/2023
Peer-reviewed
Oui
Volume
11
Numéro
2
Pages
e006877
Langue
anglais
Notes
Publication types: Letter ; Comment
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Humans, Immune Checkpoint Inhibitors/adverse effects, Cholangitis/chemically induced, Autoimmunity, CTLA-4 Antigen, Cytotoxicity, Immunologic, Immunotherapy, Programmed Cell Death 1 Receptor
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/03/2023 13:44
Dernière modification de la notice
21/07/2023 6:08